Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludarabine, Idarubicin, and Cytarabine in Pediatric Relapsed/Refractory ALL
NCT00003729Phase 2Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Dec 1998
- Primary completion
- Apr 2002
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 3
01
Overview
A Phase 2 trial of fludarabine, idarubicin, cytarabine in acute lymphoblastic leukemia (ALL), sponsored by European Organisation for Research and Treatment of Cancer. Started Dec 1998; status: terminated.
02
Drugs
fludarabineidarubicincytarabine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00003729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003729.